Updated: 1 Dec
Gavin Newsom remains a leading figure in the Democratic field for the 2028 presidential primary, attracting significant attention through legislative successes like the implementation of the “No Secret Police Act” and a decisive redistricting victory favoring Democrats.Newsom is further supported by Hollywood donors impressed by his expansion of the film and TV tax incentive program to $750 million annually and by his confrontations with Donald Trump, whom he has outperformed in polls and legal battles.
Tags

#USA

#LosAngeles

#GavinNewsom

#Democrats

#DonaldTrump

#NoSecretPoliceAct

#Hollywood

Read more
Boston Globe Deadline
Discuss
Español
Français
Deutsch
Italiano
Svenska
6
Earth
USA
Europe
Tags

#GavinNewsom

#

DonaldTrump

The US Supreme Court has upheld the Texas electoral map, allowing officials to implement a redistricting plan widely connected to Donald Trump and the Republican strategy for maintaining control of Congress. Critics...

Fri/Sat
#

HalleBerry

Halle Berry criticized Gavin Newsom at the DealBook Summit for vetoing the Menopause Care Equity Act for two consecutive years, arguing this shows disregard for women's health. Newsom, who did not respond directly at...

4 Dec/Fri
#

DonaldTrump

Donald Trump was repeatedly observed struggling with drowsiness during a recent Cabinet meeting at the White House, closing his eyes multiple times and dozing while Marco Rubio and other officials spoke. Despite public...

3 Dec/Fri
#

DonaldTrump

Donald Trump unleashed over 160 posts on Truth Social, including far-right conspiracy theories, attacks on political rivals such as Joe Biden, Michelle Obama, Barack Obama, Nancy Pelosi, Mark Kelly, Gavin Newsom, Kamala...

2 Dec/4 Dec
#

GavinNewsom

Gavin Newsom remains a leading figure in the Democratic field for the 2028 presidential primary, attracting significant attention through legislative successes like the implementation of the “No Secret Police Act” and a...

1 Dec
Threads Facebook X Instagram Bluesky
Terms Privacy
Stockholm, Sweden
+46 (0)8 525-171-42 Email